Brand Name
Osphena
Generic Name
Ospemifene
View Brand Information FDA approval date: April 01, 2023
Classification: Estrogen Agonist/Antagonist
Form: Tablet
What is Osphena (Ospemifene)?
OSPHENA is indicated for: OSPHENA is an estrogen agonist/antagonist indicated for: The treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment